Teva submits BLA for G-CSF

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) submitted a BLA to FDA for XM02 to treat chemotherapy-induced neutropenia. The product was approved last year in Europe, where it is known as TevaGras...